Febbo Phillip G.'s Form 4 filing
Veracyte, Inc. (VCYT) · filed Mar 6, 2025
- Accession no.
- 0001384101-25-000032
- Filed
- Mar 6, 2025
- Trade date
- Mar 4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $268.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo Phillip G.CIK 0001649245 | Officer (Chief Scientific & Med Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. Sale prices for the transactions range from $32.50 to $33.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $33.56 to $34.42. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.